
Inhibikase Therapeutics, Inc.
USD1.96
+0.03 (+1.30%)
CEO
Mark T. Iwicki
IPO Date
2020-12-23
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$1.93
Prev. Close
$1.93
Day Low
$1.92
Day High
$1.96
52W Low
$1.33
52W High
$2.26
Market Cap
$0.26B
Volume
0.62M
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock